医学
吉西他滨
内科学
奥沙利铂
叶黄素
伊立替康
临床终点
胃肠病学
养生
临床研究阶段
胰腺癌
无进展生存期
不利影响
外科
随机对照试验
癌症
化疗
结直肠癌
作者
Masato Ozaka,Kohei Nakachi,Satoshi Kobayashi,Akihiro Ohba,Hiroshi Imaoka,Takeshi Terashima,Hiroshi Ishii,Junki Mizusawa,Hiroshi Katayama,Tomoko Kataoka,Takuji Okusaka,Masafumi Ikeda,Naoki Sasahira,Haruo Miwa,Eishiro Mizukoshi,Naohiro Okano,Nobumasa Mizuno,Tomohisa Yamamoto,Yoshito Komatsu,Akiko Todaka
标识
DOI：10.1016/j.ejca.2022.12.014
摘要
GnP was considered the candidate for a subsequent phase III trial because of its better RR, CA19-9 response, and mild gastrointestinal toxicities. Both regimens displayed higher efficacy in the 1-year survival than in the historical data of gemcitabine monotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
smottom
无极微光
你嵙这个期刊没买
BowieHuang
Twonej
Criminology34
蜀安
科妍通AI2_1
专注的问寒
小青椒
yznfly
wy.he
DTOU
curry
wanci
机灵柚子
tuanheqi
HOAN
风清扬
轨迹
sxb10101
子车茗
Singularity
zhonglv7
皖公网安备34019202002308
